Fortress Biotech, Inc. (FBIO)
2.735
-0.04
(-1.26%)
USD |
NASDAQ |
Aug 31, 16:00
2.74
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Cash from Operations (TTM) : 120.36M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 120.36M |
| March 31, 2026 | 152.08M |
| December 31, 2025 | -71.34M |
| September 30, 2025 | -15.14M |
| June 30, 2025 | -80.09M |
| March 31, 2025 | -74.37M |
| December 31, 2024 | -80.19M |
| September 30, 2024 | -153.22M |
| June 30, 2024 | -98.94M |
| March 31, 2024 | -110.39M |
| December 31, 2023 | -128.22M |
| September 30, 2023 | -141.13M |
| June 30, 2023 | -167.75M |
| March 31, 2023 | -175.88M |
| December 31, 2022 | -179.52M |
| September 30, 2022 | -168.28M |
| June 30, 2022 | -147.08M |
| March 31, 2022 | -141.71M |
| December 31, 2021 | -116.54M |
| September 30, 2021 | -100.42M |
| June 30, 2021 | -102.12M |
| March 31, 2021 | -83.48M |
| December 31, 2020 | -83.68M |
| September 30, 2020 | -88.25M |
| June 30, 2020 | -80.62M |
| Date | Value |
|---|---|
| March 31, 2020 | -91.53M |
| December 31, 2019 | -94.96M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -101.27M |
| June 30, 2018 | -103.41M |
| March 31, 2018 | -101.02M |
| December 31, 2017 | -85.80M |
| September 30, 2017 | -79.01M |
| June 30, 2017 | -60.93M |
| March 31, 2017 | -46.62M |
| December 31, 2016 | -45.63M |
| September 30, 2016 | -24.98M |
| June 30, 2016 | -22.70M |
| March 31, 2016 | -23.18M |
| December 31, 2015 | -20.38M |
| September 30, 2015 | -26.77M |
| June 30, 2015 | -22.55M |
| March 31, 2015 | -18.70M |
| December 31, 2014 | -15.94M |
| September 30, 2014 | -19.54M |
| June 30, 2014 | -24.44M |
| March 31, 2014 | -28.23M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -80.58M |
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Kura Oncology, Inc. | -111.76M |
| Spero Therapeutics, Inc. | 19.58M |
| Cue Biopharma, Inc. | -50.05M |